Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds

Open access

Abstract

E1210 is a new antifungal compound with a novel mechanism of action and broad spectrum of antifungal activity. We investigated the in vitro antifungal activities of E1210 compared to those of fluconazole, itraconazole, voriconazole, amphotericin B, and micafungin against clinical fungal isolates. E1210 showed potent activities against most Candida spp. (MIC 90 of ≤0.008 to 0.06 μg/ml), except for Candida krusei (MICs of 2 to >32 μg/ml). E1210 showed equally potent activities against fluconazole-resistant and fluconazole-susceptible Candida strains. E1210 also had potent activities against various filamentous fungi, including Aspergillus fumigatus (MIC 90 of 0.13 μg/ml). E1210 was also active against Fusarium solani and some black molds. Of note, E1210 showed the greatest activities against Pseudallescheria boydii (MICs of 0.03 to 0.13 μg/ml), Scedosporium prolificans (MIC of 0.03 μg/ml), and Paecilomyces lilacinus (MICs of 0.06 μg/ml) among the compounds tested. The antifungal action of E1210 was fungistatic, but E1210 showed no trailing growth of Candida albicans , which has often been observed with fluconazole. In a cytotoxicity assay using human HK-2 cells, E1210 showed toxicity as low as that of fluconazole. Based on these results, E1210 is likely to be a promising antifungal agent for the treatment of invasive fungal infections.

Overview

Integrity signals

Registry

Crossref · 10.1128/aac.00291-11

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

The citation lists are queued

They are fetched later and appear here then.

References 23 · Cited by 200

Research works printed but not linked: 6

  1. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi: approved standard, 2nd ed. CLSI document M38-A2. CLSI, Wayne, PA.
  2. HataK. HoriiT. MiyazakiM. WatanabeN.. 2010. Abstr. 50th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-842.
  3. HoriiT. OkuboM. MiyazakiM. HataK. WatanabeN.. 2010. Abstr. 50th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-843.
  4. OkuboM. ToritsukaN. HoriiT. HataK. SonodaJ.. 2010. Abstr. 50th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-844.
  5. RennieR. SandC. SherburneR.. 1997. Electron microscopic evidence of the effect of LY303366 on Aspergillus fumigatus. Abstr. 13th Congr. Int. Soc. Hum. Animal Mycol., abstr. P451.
  6. WatanabeN. MiyazakiM. HoriiT. HataK.. 2010. Abstr. 50th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-841.

Metadata

Authors
Miyazaki, M., Horii, T., Hata, K., Watanabe, N.-A., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., Inoue, S., Matsukura, M., Abe, S., Yoshimatsu, K., & Asada, M.
Affiliations
  • Eisai (Japan) (JP)
  • Next Generation Systems Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki, Japan
Venue
Antimicrobial Agents and Chemotherapy
Published
2011-10
Volume
55
Issue
10
Pages
4652-4658
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2114599108
Cited by
200
References
23
Citations by year
2026: 14 · 2025: 15 · 2024: 21 · 2023: 16 · 2022: 18 · 2021: 16 · 2020: 22 · 2019: 18 · 2018: 16 · 2017: 12 · 2016: 7 · 2015: 4 · 2014: 10 · 2013: 4 · 2012: 3
FWCI
4.54
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
antifungal agents, Candida, Candida albicans, Candida krusei, Aspergillus fumigatus, Fusarium solani, Pseudallescheria boydii, Scedosporium prolificans, Paecilomyces lilacinus, black mold, fluconazole resistance, invasive fungal infections, fungistatic activity, cytotoxicity, HK-2 cells, minimum inhibitory concentration
MeSH terms
Micafungin, Aminopyridines, Amphotericin B, Antifungal Agents, Aspergillus, Candida, Cell Line, Fungi, Fusarium, Humans, Isoxazoles, Microbial Sensitivity Tests, Paecilomyces, Pseudallescheria, Pyrimidines, Triazoles, Yeasts, Fluconazole, Itraconazole, Scedosporium, Echinocandins, Lipopeptides, Voriconazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds. https://app.cochat.ai/papers/10.1128/aac.00291-11
The paper
Miyazaki, M., Horii, T., Hata, K., Watanabe, N.-A., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., Inoue, S., Matsukura, M., Abe, S., Yoshimatsu, K., & Asada, M. (2011). In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00291-11

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.